Boundary Capital Partners
Overview
Boundary Capital Partners is an impact venture capital firm founded in 2009 and based in London, UK. The firm focuses on investing in high-growth, private B2B technology companies that have a positive societal impact. Its specialist investment themes are Life Science technologies, Engineering innovations for sustainability, and Software and data science. The firm manages several funds, including the Impact Life Fund and a new EIS AI Fund launched in 2024. Boundary Capital's investment model often involves placing experienced executives ('Venturers') who also invest in the business to provide sector-specific expertise and connections. Investments typically range from late seed stage to Series B.
Portfolio Companies
3
Website
boundarycapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| 4D Biomaterials | Jul 2024 | Series A | Co-investor |
| Inotec AMD Ltd | Feb 2020 | VC Round | Co-investor |
| Echion Technologies | Nov 2018 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.